Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about VEGF: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | VEGF |
| Aliases | Vascular Endothelial Growth Factor |
| Function | VEGF serves multiple physiological functions |
| Primary Expression | hippocampus, motor cortex, cerebellum, cortex, striatum |
| Pathways | Akt, Amyloid, Apoptosis, Complement, Epigenetic |
| UniProt ID | [P15692](https://www.uniprot.org/uniprot/P15692) |
| NCBI Gene ID | 7422 |
| GeneCards | VEGF |
| Human Protein Atlas | VEGF |
| Associated Diseases | ALS, Aging, Alzheimer, Alzheimer'S Disease |
| Known Drugs/Compounds | RAPAMYCIN, bevacizumab, levodopa, LEVODOPA, QUERCETIN, rapamycin |
| Interactions | FGF2, ANGPT1, PDGFRB, VEGFB, BMP2, STAT3 |
| KG Connections | 1347 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
BMAL1["BMAL1<br/>Circadian Regulator"]
HIF1A["HIF1A<br/>Hypoxia-Inducible Factor"]
VEGF["VEGF<br/>Vascular Endothelial<br/>Growth Factor"]
Angiogenesis["Angiogenesis<br/>Blood Vessel Formation"]
bevacizumab["Bevacizumab<br/>Anti-VEGF Therapy"]
ALS["ALS<br/>Amyotrophic Lateral<br/>Sclerosis"]
MS["Multiple Sclerosis<br/>Demyelinating Disease"]
Alzheimer["Alzheimer's Disease<br/>Neurodegeneration"]
Dementia["Dementia<br/>Cognitive Decline"]
TBI["Traumatic Brain Injury<br/>Acute Injury"]
Neuropathy["Neuropathy<br/>Nerve Damage"]
Inflammation["Inflammation<br/>Immune Response"]
Cancer["Cancer<br/>Malignancy"]
BMAL1 --|"regulates"|--> VEGF
HIF1A --|"regulates"|--> VEGF
VEGF --|"promotes"|--> Angiogenesis
bevacizumab --|"inhibits"|--> VEGF
VEGF --|"activates"|--> ALS
VEGF --|"expressed in"|--> MS
VEGF --|"associated with"|--> Alzheimer
VEGF --|"associated with"|--> Dementia
VEGF --|"protective against"|--> TBI
VEGF --|"expressed in"|--> Neuropathy
VEGF --|"associated with"|--> Inflammation
VEGF --|"activates"|--> Cancer
Angiogenesis --|"supports"|--> TBI
Inflammation --|"contributes to"|--> ALS
Inflammation --|"contributes to"|--> MS
style VEGF fill:#006494
style BMAL1 fill:#4a1a6b
style HIF1A fill:#4a1a6b
style bevacizumab fill:#1b5e20
style Angiogenesis fill:#1b5e20
style TBI fill:#1b5e20
style ALS fill:#ef5350
style MS fill:#ef5350
style Alzheimer fill:#ef5350
style Dementia fill:#ef5350
style Inflammation fill:#ef5350
style Cancer fill:#ef5350
style Neuropathy fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Ischemia | activates | disease | 1.00 |
| Angiogenesis | activates | pathway | 1.00 |
| Als | activates | disease | 0.95 |
| neovascularization | activates | process | 0.91 |
| Vascular Remodelling | involved_in | process | 0.90 |
| POEMS Syndrome | involved_in | disease | 0.90 |
| colorectal cancer | therapeutic_target | disease | 0.90 |
| VASCULAR PERMEABILITY | regulates | biological_process | 0.90 |
| endothelial cells | expressed_in | cell_type | 0.90 |
| AKT | therapeutic_target | gene | 0.90 |
| MTOR | therapeutic_target | gene | 0.90 |
| Angiogenesis | inhibits | entity | 0.90 |
| Mtor | therapeutic_target | pathway | 0.90 |
| Glymphatic Transport | regulates | process | 0.85 |
| Cognitive Function | involved_in | phenotype | 0.85 |
| Cancer | activates | disease | 0.85 |
| Als | inhibits | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| Tumor | inhibits | disease | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Colorectal Cancer | therapeutic_target | disease | 0.85 |
| Angiogenesis | promotes | process | 0.85 |
| Breast Cancer | biomarker_for | disease | 0.85 |
| Methamphetamine Toxicity | involved_in | mechanism | 0.82 |
| ERK | activates | protein | 0.82 |
| PI3K | activates | gene | 0.80 |
| IPF | inhibits | disease | 0.80 |
| APOE4 | reverses | protein | 0.80 |
| Crow-Fukase syndrome | biomarker_for | disease | 0.80 |
| Tumor Progression | involved_in | process | 0.80 |
| endothelial cells | associated_with | cell_type | 0.80 |
| unfolded protein response | participates_in | pathway | 0.80 |
| endothelial cells | regulates | cell_type | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| ALS | biomarker_for | disease | 0.80 |
| blood-brain barrier | participates_in | pathway | 0.80 |
| EGFR | therapeutic_target | gene | 0.80 |
| Angiogenesis | regulates | entity | 0.80 |
| GENES | activates | gene | 0.80 |
| Mapk | therapeutic_target | pathway | 0.80 |
| TNF-Α | activates | gene | 0.80 |
| Mapk | activates | pathway | 0.80 |
| Nf-Κb | therapeutic_target | pathway | 0.80 |
| CANCER | inhibits | gene | 0.80 |
| Angiogenesis | therapeutic_target | pathway | 0.80 |
| Angiogenesis | associated_with | pathway | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| bevacizumab | binds_to | drug | 0.95 |
| BMAL1 | regulates | gene | 0.90 |
| Irisin | upregulates | protein | 0.90 |
| HIF1A | upregulates | gene | 0.90 |
| Hu-Loaded Exosomes | downregulates | compound | 0.90 |
| PI3K | therapeutic_target | gene | 0.90 |
| SRPK1 | upregulates | protein | 0.85 |
| Hypoxia Response Elements | regulates | mechanism | 0.85 |
| HIF-1 | upregulates | protein | 0.85 |
| HIF1A | regulates | gene | 0.80 |
| TEK | phosphorylates | protein | 0.80 |
| APOE4 | downregulates | protein | 0.80 |
| Adrenergic Receptor Blocker | upregulates | drug | 0.80 |
| aerobic exercise | activates | process | 0.80 |
| ENDOTHELIAL CELLS | regulates | cell_type | 0.80 |
| TNF | activates | gene | 0.80 |
| STAT3 | activates | gene | 0.80 |
| TNF | associated_with | gene | 0.74 |
| bevacizumab | inhibits | drug | 0.70 |
| EGFR | therapeutic_target | gene | 0.70 |
| SEMA3F | downregulates | gene | 0.70 |
| TH | inhibits | gene | 0.70 |
| TH | regulates | gene | 0.70 |
| SRPK1 | inhibits | gene | 0.70 |
| SRPK1 | regulates | gene | 0.70 |
| MMP2 | expressed_in | gene | 0.70 |
| MMP9 | expressed_in | gene | 0.70 |
| Angiogenesis | interacts_with | entity | 0.70 |
| P53 | associated_with | gene | 0.70 |
| RUNX2 | activates | gene | 0.70 |
| ERK | therapeutic_target | gene | 0.70 |
| CYTOKINES | regulates | gene | 0.70 |
| ROS | activates | gene | 0.70 |
| HIF | activates | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| NF-ΚB | therapeutic_target | gene | 0.70 |
| TNF-α | upregulates | protein | 0.70 |
| NEUROGENESIS | regulates | phenotype | 0.70 |
| BAX | activates | gene | 0.66 |
| JUN | associated_with | gene | 0.66 |
| AKT | activates | gene | 0.66 |
| APOE | associated_with | gene | 0.66 |
| TAU | associated_with | protein | 0.66 |
| IL-6 | associated_with | gene | 0.66 |
| PARKINSON'S DISEASE | associated_with | disease | 0.66 |
| AMYLOID | associated_with | protein | 0.66 |
| STING | increases | gene | 0.65 |
| TAU | biomarker_for | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||